IL84223A0 - Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement - Google Patents

Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement

Info

Publication number
IL84223A0
IL84223A0 IL84223A IL8422387A IL84223A0 IL 84223 A0 IL84223 A0 IL 84223A0 IL 84223 A IL84223 A IL 84223A IL 8422387 A IL8422387 A IL 8422387A IL 84223 A0 IL84223 A0 IL 84223A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
receptor agonists
adrenergic receptor
containing alpha
Prior art date
Application number
IL84223A
Other languages
English (en)
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of IL84223A0 publication Critical patent/IL84223A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL84223A 1986-11-07 1987-10-20 Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement IL84223A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/928,442 US4847300A (en) 1986-11-07 1986-11-07 Use of alpha-2I selective adrenergic receptor agonists in memory enhancement

Publications (1)

Publication Number Publication Date
IL84223A0 true IL84223A0 (en) 1988-03-31

Family

ID=25456234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84223A IL84223A0 (en) 1986-11-07 1987-10-20 Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement

Country Status (12)

Country Link
US (1) US4847300A (xx)
EP (1) EP0268912A3 (xx)
JP (1) JPS63183524A (xx)
KR (1) KR880005926A (xx)
AU (1) AU601771B2 (xx)
CA (1) CA1307741C (xx)
DK (1) DK546287A (xx)
IE (1) IE872994L (xx)
IL (1) IL84223A0 (xx)
NZ (1) NZ222464A (xx)
PH (1) PH23840A (xx)
PT (1) PT86059B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
US5854290A (en) * 1995-09-21 1998-12-29 Amy F. T. Arnsten Use of guanfacine in the treatment of behavioral disorders
AU2006251832A1 (en) * 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
WO2007010242A1 (en) * 2005-07-18 2007-01-25 Imperial College Innovations Limited Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
FR2893844B1 (fr) * 2005-11-28 2008-02-01 Centre Nat Rech Scient Utilisation du guanabenz et de ses derives pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
US20120041068A1 (en) * 2010-08-11 2012-02-16 Aptapharma, Inc. Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE893276A (fr) * 1981-06-01 1982-11-24 Sandoz Sa Nouvelle application therapeutique d'un derive de l'acetamide
CH649918A5 (de) * 1981-07-09 1985-06-28 Sandoz Ag Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie.

Also Published As

Publication number Publication date
AU7977087A (en) 1988-05-12
DK546287D0 (da) 1987-10-19
JPS63183524A (ja) 1988-07-28
NZ222464A (en) 1990-08-28
US4847300A (en) 1989-07-11
PT86059B (pt) 1990-07-31
AU601771B2 (en) 1990-09-20
DK546287A (da) 1988-05-08
EP0268912A2 (en) 1988-06-01
IE872994L (en) 1988-05-07
PT86059A (en) 1987-12-01
KR880005926A (ko) 1988-07-21
EP0268912A3 (en) 1990-02-28
PH23840A (en) 1989-11-23
CA1307741C (en) 1992-09-22

Similar Documents

Publication Publication Date Title
GB2193633B (en) Psycho-active pharmaceutical compositions containing indolyl derivatives
HUT47500A (en) Feeding package for liquid matters
DE3262386D1 (en) Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
EP0246767A3 (en) Semiconductor memories
IL71126A0 (en) Azole compounds,their preparation and pharmaceutical compositions containing them
SG93290G (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
IL70966A0 (en) Imidazoline derivatives and related compounds,their preparation and pharmaceutical compositions containing them
ZA849499B (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
IL71203A0 (en) Azoles,their preparation and pharmaceutical compositions containing them
ZA851563B (en) Pharmaceutical compositions containing quaternary 3,4-dihydroisoquinolinium salts
IL82645A0 (en) Pharmaceutical compositions containing polypeptides
IL84223A0 (en) Pharmaceutical compositions containing alpha-21 selective adrenergic receptor agonists for memory enhancement
GB8705516D0 (en) Capsule holder
NZ220747A (en) Pharmaceutical compositions containing 1,3-oxazolidin-2- one derivatives
ZA876540B (en) New sulphonamidoethyl compounds,pharmaceutical compositions containing these compounds and processes for preparing them
KR910006110B1 (en) Memory device using address multiplexing
GR890100177A (en) Process for preparing pharmaceutical compositions containing sodium cromoclycate
EP0282895A3 (en) 2-oxa-isocephem compounds, compositions containing same and processes for preparing same
IL76837A0 (en) Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
GR870422B (en) Method for preparing pharmaceutical compositions containing vinburnine
GB8615206D0 (en) Memory address system
DE3461376D1 (en) N-cyano-formamidine compounds, process for preparing them and pharmaceutical compositions containing them
GB8612080D0 (en) Package for ingredients
CS928186A1 (en) Agent for cow natality increase